More than 30 Black women’s organizations say FDA should set up an advisory committee focused on racial and gender equity in clinical trials and revise its Institutional Review Board policies to ensure Black women, femmes, girls and gender-expansive people are represented in clinical trials and equitably compensated for their participation. The recommendations are part of a broad Black Reproductive Justice Policy Agenda released Tuesday (June 15) by In Our Own Voice: National Black Women’s Reproductive Justice Agenda, Interfaith Voices for...